Dynavax Ownership | Who Owns Dynavax?

Overview Forecast RevenueFinancials Chart Transcripts

Dynavax Ownership Summary

Dynavax is owned by 15.06% institutional investors, 0.75% insiders, and 84.19% retail investors. Blackrock is the largest institutional shareholder, holding 16.73% of DVAX shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.67% of its assets in Dynavax shares.

DVAX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Dynavax	15.06%	0.75%	84.19%
Sector	Healthcare Stocks	35.58%	11.87%	52.55%
Industry	Specialty & Generic Drug Manufacturers Stocks	20.67%	13.90%	65.43%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	21.90M	16.73%	$245.97M
Vanguard group	8.03M	6.84%	$123.46M
Goldman sachs group	2.15M	1.84%	$33.13M
Two sigma advisers, lp	1.58M	1.33%	$15.71M
Glenmede investment management, lp	1.26M	1.06%	$12.56M
Glenmede trust co na	1.11M	0.85%	$12.47M
Bank of america corp /de/	1.00M	0.77%	$11.26M
Norges bank	607.80K	0.46%	$7.76M
Cubist systematic strategies	446.75K	0.37%	$4.44M
Nuveen asset management	348.39K	0.27%	$4.45M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Highvista strategies	192.85K	0.47%	$1.91M
Quantedge capital pte	52.90K	0.29%	$525.30K
Parkman healthcare partners	271.31K	0.28%	$2.69M
Corton capital	10.72K	0.26%	$106.45K
Adar1 capital management	170.00K	0.16%	$1.69M
Advantage alpha capital partners lp	25.89K	0.08%	$257.11K
Bayesian capital management, lp	35.90K	0.07%	$356.49K
Clarivest asset management	61.45K	0.07%	$690.06K
Glenmede trust co na	1.11M	0.06%	$12.47M
Glenmede investment management, lp	1.26M	0.06%	$12.56M

Top Buyers

Holder	Shares	% Assets	Change
Norges bank	607.80K	0.00%	607.80K
Glenmede trust co na	1.11M	0.06%	547.54K
Goldman sachs group	2.15M	0.00%	291.42K
Glenmede investment management, lp	1.26M	0.06%	243.24K
Cubist systematic strategies	446.75K	0.02%	179.49K

Top Sellers

Holder	Shares	% Assets	Change
Blackrock funding, inc. /de	-	-	-16.31M
Deep track capital, lp	-	-	-15.73M
State street	-	-	-7.16M
Deerfield management company, l.p. (series c)	-	-	-5.19M
Chicago capital	-	-	-3.47M

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	607.80K	0.00%	607.80K	$7.76M
Quantedge capital pte	52.90K	0.29%	52.90K	$525.30K
Jump financial	15.53K	0.00%	15.53K	$154.20K
Nebula research & development	14.60K	0.01%	14.60K	$144.82K
Capstone investment advisors	13.18K	0.00%	13.18K	$130.83K

Sold Out

Holder	Change
Natixis	-1.00
Rfp financial group	-1.00
Fortitude family office	-1.00
Sjs investment consulting	-1.00
Root financial partners	-1.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	76	-72.76%	17,667,160	-84.40%	15	0.17%	34	-70.43%	29	-74.56%
Sep 30, 2025	105	-60.97%	20,912,060	-81.73%	17	0.19%	38	-64.81%	45	-62.18%
Jun 30, 2025	265	-7.67%	114,305,280	-10.42%	95	0.92%	106	-19.08%	117	17.00%
Mar 31, 2025	286	7.12%	127,346,655	-2.45%	101	1.03%	132	-3.65%	100	26.58%
Dec 31, 2024	266	3.10%	130,543,648	0.76%	99	1.02%	136	20.35%	79	-14.13%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
iShares Core S&P Small-Cap ETF	6.64M	5.67%	-
Vanguard US Total Market Shares ETF	4.19M	3.38%	5.93K
Vanguard Total Stock Mkt Idx Inv	3.75M	3.30%	-
Federated Hermes Kaufmann Small Cap Grow	3.30M	2.52%	-550.00K
Federated Hermes Kaufmann Small Cap A	3.30M	2.52%	-550.00K
iShares Russell 2000 ETF	2.57M	2.19%	-
Federated Hermes Kaufmann Growth	2.22M	1.70%	-850.70K
Federated Hermes Kaufmann R	2.22M	1.70%	-850.70K
SPDR® S&P Biotech ETF	1.98M	1.69%	4.42K
Invesco Small Cap Value A	1.21M	1.01%	-136.52K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jan 15, 2026	Novack David F	President & COO	Sell	$1.78M
Dec 24, 2025	Novack David F	President & COO	Sell	$464.70K
Aug 22, 2025	Myers Scott Dunseth	-	Buy	$41.12K
Aug 22, 2025	Deep Track Biotechnology Master Fund, Ltd.	-	Sell	$10.27M
Aug 21, 2025	Deep Track Biotechnology Master Fund, Ltd.	-	Sell	$12.08M

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	-	1
2025 Q4	-	1
2025 Q3	1	2
2025 Q2	-	-
2025 Q1	-	3

DVAX Ownership FAQ

Who Owns Dynavax?

Dynavax shareholders are primarily institutional investors at 15.06%, followed by 0.75% insiders and 84.19% retail investors. The average institutional ownership in Dynavax's industry, Specialty & Generic Drug Manufacturers Stocks, is 20.67%, which Dynavax falls below.

Who owns the most shares of Dynavax?

Dynavax’s largest shareholders are Blackrock (21.9M shares, 16.73%), Vanguard group (8.03M shares, 6.84%), and Goldman sachs group (2.15M shares, 1.84%). Together, they hold 25.41% of Dynavax’s total shares outstanding.

Does Blackrock own Dynavax?

Yes, BlackRock owns 16.73% of Dynavax, totaling 21.9M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 245.97M$. In the last quarter, BlackRock decreased its holdings by -1.288M shares, a -5.55% change.

Who is Dynavax’s biggest shareholder by percentage of total assets invested?

Highvista strategies is Dynavax’s biggest shareholder by percentage of total assets invested, with 0.47% of its assets in 192.85K Dynavax shares, valued at 1.91M$.

Who is the top mutual fund holder of Dynavax shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Dynavax shares, with 5.67% of its total shares outstanding invested in 6.64M Dynavax shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools